ArticleEndocrine2024

Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States.

Francis Worden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.